用户验证的应用
推荐稀释比例
- IHC-P1/2000 Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- WB1/1000
- ICC/IF1/50
- IHC-Fr1/500
详细信息
背景信息
What is this antibody validated in? Anti-CD206 antibody [EPR25215-277] (ab300621) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Immunohistochemistry (IHC-P), Immunohistochemistry (IHC-Fr), Immunocytochemistry/immunofluorescence (ICC/IF) in Mouse, Rat samples. What is the molecular weight of CD206? Anti-CD206 [EPR25215-277] (ab300621) specifically detects a band for CD206 (UniProt: Q61830) at a molecular weight of 166kDa. Other related products We have a range of other formats of antibody clone [EPR25215-277] also available for your convenience: ab300621, Carrier free - ab300622, PE - ab318396, APC - ab318499, Alexa Fluor ® 488 - ab318602, Alexa Fluor ® 647 - ab318705, Alexa Fluor ® 594 - ab318808, Alexa Fluor ® 555 - ab318908, Alexa Fluor ® 750 - ab321549 Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies. Trial sizes available! Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 20µl. Discover our selection of trial-size antibodies.
文献引用 (60)
Sulfated polysaccharide facilitates macrophage-Treg crosstalk to mitigate chronic inflammation in diabetic wound healing.
硫酸多糖促进巨噬细胞-Treg细胞相互作用,从而减轻糖尿病伤口愈合中的慢性炎症。
CEBPB-high dormant tumor cells drive immune evasion via S100A8 orchestrated tumor-associated macrophages reprogramming
CEBPB高表达的休眠肿瘤细胞通过S100A8调控的肿瘤相关巨噬细胞重编程驱动免疫逃逸
Tet2 deficiency-induced expansion of monocyte-derived macrophages promotes liver fibrosis.
Tet2 缺乏诱导的单核细胞衍生巨噬细胞扩增促进肝纤维化。
DNASE1L3 Mediates Hepatocellular Carcinoma Tumor Growth and Organoid Models via the Wnt/β-Catenin Signaling Pathway.
DNASE1L3 通过 Wnt/β-catenin 信号通路介导肝细胞癌肿瘤生长和类器官模型。
One-step strategy for fabricating icariin-encapsulated biomimetic Scaffold: Orchestrating immune, angiogenic, and osteogenic cascade for enhanced bone regeneration.
一步法制备淫羊藿苷包封仿生支架:协调免疫、血管生成和成骨级联反应以增强骨再生
Modular assembled biomimetic nanobubbles for synergistic therapy of ischemic stroke via cascade modulation thrombo-inflammatory network.
模块化组装仿生纳米气泡通过级联调节血栓炎症网络协同治疗缺血性中风
A sandwich-like nanofibrous scaffold with macrophage phenotype transformation and myogenic differentiation for skeletal muscle regeneration
一种具有巨噬细胞表型转化和成肌分化能力的三明治状纳米纤维支架,可用于骨骼肌再生
β-Mangostin Attenuates TET2-Mediated DNA Demethylation of Prkcg in the Prevention of Intervertebral Disc Degeneration.
β-倒捻子素减弱TET2介导的Prkcg DNA去甲基化,从而预防椎间盘退变
Regulation of immune microenvironments by polyetheretherketone surface topography for improving osseointegration.
通过聚醚醚酮表面形貌调节免疫微环境以改善骨整合
Inhibiting KRAS with CD47 and immune checkpoint overcomes intrinsic resistance to combined KRAS and immune checkpoint inhibitor therapy
利用 CD47 和免疫检查点抑制剂抑制 KRAS 可克服对 KRAS 和免疫检查点抑制剂联合疗法的内在耐药性。
- 1
- 2
- 3
- 4
- 5
- 6